申请人:Arend P. Michael
                            
                            
                                公开号:US20060217416A1
                            
                            
                                公开(公告)日:2006-09-28
                            
                            The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
                            本发明涉及适用于介导缺氧诱导因子和治疗红细胞生成素相关疾病的化合物,通过在体内外增加内源性红细胞生成素来实现。